A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma
A Phase 1b/2a Multicenter, Open-label, Dose-escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination With Other Treatments in Subjects With Multiple Myeloma
Sponsor: Celgene
A PHASE1/PHASE2 clinical study on Multiple Myeloma, this trial is ongoing. The trial is conducted by Celgene and has accumulated 48 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
48 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2024 — May 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
▶ Show 43 earlier versions
-
Nov 2023 — Mar 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2023 — Oct 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2023 — Sep 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2023 — Aug 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2023 — Jul 2023 [monthly]
Recruiting PHASE1_PHASE2
-
May 2023 — Jun 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2023 — May 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2023 — Apr 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2023 — Mar 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2023 — Feb 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2022 — Jul 2022 [monthly]
Recruiting PHASE1_PHASE2
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2022 — May 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2021 — Mar 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2020 — Oct 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2020 — Aug 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2019 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2019 — Nov 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2019 — Sep 2019 [monthly]
Recruiting PHASE1_PHASE2
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2019 — May 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2018 — Nov 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2017 — Mar 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2017 — Dec 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Celgene
For direct contact, visit the study record on ClinicalTrials.gov .